Table 2.
Patient demographics (N=56)
| Characteristic | n | (%) |
|---|---|---|
| Age – years, mean (SD) | 63.7 (11.6) | |
| Gender | ||
| Male | 34 | (60.7) |
| Female | 22 | (39.3) |
| Race | ||
| White | 41 | (73.2) |
| Other | 15 | (26.8) |
| Diabetes | ||
| Yes | 47 | (83.9) |
| No | 9 | (16.1) |
| Marital status | ||
| Married | 43 | (76.8) |
| Not married | 13 | (23.2) |
| Education level | ||
| High school or less | 11 | (19.6) |
| Greater than high school | 45 | (80.4) |
| Chemotherapy regimen | ||
| Bortezomib-based | 50 | (89.3) |
| No bortezomib | 6 | (10.7) |
| Chemotherapy cycles at baseline | ||
| <1 cycle | 13 | (23.2) |
| 1-2 cycles | 43 | (76.8) |
| Total chemotherapy cycles | ||
| <5 cycles | 41 | (73.2) |
| 5 cycles | 15 | (26.8) |
SD Standard Deviation